Sanj K. Patel
2022
In 2022, Sanj K. Patel earned a total compensation of $6.1M as Chief Executive Officer and Chairman of the Board at Kiniksa Pharmaceuticals, Ltd., a 7% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $597,408 |
|---|---|
| Option Awards | $3,746,557 |
| Salary | $834,918 |
| Stock Awards | $922,039 |
| Other | $12,200 |
| Total | $6,113,122 |
Patel received $3.7M in option awards, accounting for 61% of the total pay in 2022.
Patel also received $597.4K in non-equity incentive plan, $834.9K in salary, $922K in stock awards and $12.2K in other compensation.
Rankings
In 2022, Sanj K. Patel's compensation ranked 498th out of 5,760 executives tracked by ExecPay. In other words, Patel earned more than 91.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 498 out of 5,760 | 91st |
Division Manufacturing | 203 out of 3,136 | 94th |
Major group Chemicals And Allied Products | 56 out of 1,422 | 96th |
Industry group Drugs | 44 out of 1,323 | 97th |
Industry Pharmaceutical Preparations | 30 out of 969 | 97th |
Source: SEC filing on April 27, 2023.
Patel's colleagues
We found two more compensation records of executives who worked with Sanj K. Patel at Kiniksa Pharmaceuticals, Ltd. in 2022.